Statistics for ResMed (id:8641 RMD)

Valuation metrics

Market cap

35.15B

Enterprise value

34.87B

Trailing P/E (ttm)

31.75

Forward P/E

23.27

PEG ratio

23.27

Price/Sales (ttm)

7.31

Price/Book (mrq)

6.76

Enterprise Value/Revenue

7.25

Enterprise Value/EBITDA

21.36

Overview

Shares outstanding

146.80M

Float

145.85M

Shares short

7.89M

% Held by insiders

0.01%

% Held by institutions

0.61%

Average volume (10 days)

906.38K

Average volume (90 days)

Price summary

52-Week low

151.95

52-Week high

260.49

52-Week change

36.30%

Beta

0.69

50-Day moving average

242.84

200-Day moving average

212.78

Dividends and splits

Forward annual dividend rate

2.12

Forward annual dividend yield

0.01

Trailing annual dividend rate

1.97%

Trailing annual dividend yield

0.01

5-Year annual dividend yield

0.84

Payout ratio

0.26

Dividend date

December 12th, 2024

Ex-dividend date

November 07th, 2024

Last split factor

2:1

Last split date

August 31th, 2010

Financials

Fiscal year

Fiscal year ends

June 30th, 2021

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

23.15%

Operating margin

31.63%

Operational effectiveness

Return on assets

13.27%

Return on equity

23.56%

Income statement

Revenue (ttm)

32.71

Revenue per share (ttm)

32.71

Quarterly revenue growth (yoy)

0.42

Gross profit (ttm)

2.66B

EBITDA

1.69B

Net income to common (ttm)

1.11B

Diluted EPS (ttm)

7.54

Quarterly earnings growth (yoy)

41.90%

Balance sheet

Total cash (mrq)

442.58M

Total cash per share (mrq)

3.02

Total debt (mrq)

850.24M

Total Debt/Equity (mrq)

16.37

Current ratio (mrq)

292.10%

Book value per share (mrq)

35.39

Cash flow

Cash flow statement

1.44B

Levered free cash flow (LFCF)

1.12B